Literature DB >> 26227734

Patterns of Motor and Non-Motor Features in Medication-Naïve Parkinsonism.

Samay Jain1, Seo-Young Park, Diane Comer.   

Abstract

BACKGROUND: Parkinsonism is defined by motor features (tremor, bradykinesia, rigidity, and postural instability). Accompanying non-motor features (e.g. cognitive, autonomic, sleep disturbances) are underrecognized and undertreated. We hypothesized that clinical patterns occurring in early, medication-naïve Parkinsonism are distinguished by features such as tremor, sleep, autonomic, and cognitive dysfunction.
METHODS: Clinical and neuroimaging data were obtained in the Parkinson's Progression Marker Initiative. Group comparisons of Parkinsonism with dopaminergic deficits (PDD) (n = 388), controls (n = 196), and Parkinsonism with scans without evidence of dopaminergic deficits (n = 64) were done with ANOVA, chi-square, and post-hoc pairwise tests. To examine clinical patterns within the PDD group, k-means clustering was performed with non-motor or motor features, or both.
RESULTS: Among PDD, 4 non-motor patterns (% of PDD) (impulsive (14.9%), sleep-autonomic (22.9%), cognitive-olfactory (18.0%), and mild (44.1%)), 4 motor patterns (tremor plus bradykinesia (56.2%), tremor without bradykinesia (16.2%), postural instability (6.7%) and no tremor (20.9%)) and 5 combined motor/non-motor patterns (tremor with bradykinesia (42.3%), tremor without bradykinesia (15.5%), no tremor and mild non-motor features (17.0%), postural instability with sleep-autonomic disturbances (6.7%) and oldest onset cognitive-olfactory (18.6%)) were observed.
CONCLUSIONS: To our knowledge, this is the first description of non-motor clinical patterns in early, medication-naïve Parkinsonism, suggesting that such features are intrinsic to Parkinsonian disorders.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26227734      PMCID: PMC4543435          DOI: 10.1159/000437228

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  25 in total

Review 1.  Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease.

Authors:  Wilma D J van de Berg; Dagmar H Hepp; Anke A Dijkstra; J Annemieke M Rozemuller; Henk W Berendse; E Foncke
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 2.  Improving the diagnostic accuracy in parkinsonism: a three-pronged approach.

Authors:  Marjolein B Aerts; Rianne A J Esselink; Bart Post; Bart P C van de Warrenburg; Bastiaan R Bloem
Journal:  Pract Neurol       Date:  2012-04

Review 3.  REM sleep behavior disorder: from dreams to neurodegeneration.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Jacques Y Montplaisir
Journal:  Neurobiol Dis       Date:  2011-10-14       Impact factor: 5.996

4.  Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.

Authors:  Ronald B Postuma; Anthony E Lang; Jessica Massicotte-Marquez; Jacques Montplaisir
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

Review 5.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

6.  Clinical subtypes of Parkinson's disease.

Authors:  Stephanie M van Rooden; Fabrice Colas; Pablo Martínez-Martín; Martine Visser; Dagmar Verbaan; Johan Marinus; Ray K Chaudhuri; Joost N Kok; Jacobus J van Hilten
Journal:  Mov Disord       Date:  2010-11-16       Impact factor: 10.338

Review 7.  The Parkinson Progression Marker Initiative (PPMI).

Authors: 
Journal:  Prog Neurobiol       Date:  2011-09-14       Impact factor: 10.885

8.  Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.

Authors:  Daniel Weintraub
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

Review 9.  Cognitive reserve in ageing and Alzheimer's disease.

Authors:  Yaakov Stern
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

10.  Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs).

Authors:  L Silveira-Moriyama; P Schwingenschuh; A O'Donnell; S A Schneider; P Mir; F Carrillo; C Terranova; A Petrie; D G Grosset; N P Quinn; K P Bhatia; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-03-09       Impact factor: 10.154

View more
  1 in total

1.  Non-motor Clinical and Biomarker Predictors Enable High Cross-Validated Accuracy Detection of Early PD but Lesser Cross-Validated Accuracy Detection of Scans Without Evidence of Dopaminergic Deficit.

Authors:  Charles Leger; Monique Herbert; Joseph F X DeSouza
Journal:  Front Neurol       Date:  2020-05-11       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.